The Food and Drug Administration (FDA ... ST316, an investigational β-catenin and BCL9 interaction peptide antagonist, inhibits the Wnt enhanceosome protein complex formulation that leads ...

Percent of members 18 years or older with a prescription for a blood pressure medication (RAS antagonist) who fill their prescription often enough to cover 80% or more of the time they are supposed to ...